Search Results
Jun 08, 2026, 12:56 ET Greenfield Savings Bank Celebrates Grand Opening of Easthampton Branch
location strengthens local relationships and expands the bank's presence in Hampshire CountyGREENFIELD, Mass., June 8, 2026 /PRNewswire/ -- Greenfield Savings Bank celebrated the grand opening and ribbon cutting of its
More news about: Greenfield Savings Bank
Jun 08, 2026, 12:00 ET ECA POWER STRENGTHENS EXECUTIVE LEADERSHIP TEAM WITH THE ADDITION OF BEN HOUSMAN
Key Internal Promotions Support ECA's Continued Expansion and GrowthWALTHAM, Mass., June 8, 2026 /PRNewswire/ -- ECA Power today announced the appointment of Ben Housman as Vice President of Project
More news about: ECA Power
Jun 08, 2026, 11:25 ET OLAY's #1 Cream Collection in Asia* Comes to the U.S. with Brenda Song as Brand Ambassador
$55.00.About OLAYOLAY is a worldwide leader in skin care and has been trusted by women for over 70 years. In 2021, it became the first mass skin care brand in the US to commit to zero skin retouching in all advertising to show real results. With a belief in an inclusive beauty standard,
More news about: OLAY
Jun 08, 2026, 10:45 ET T. ROWE PRICE MARKS 50 YEARS OF MONEY MARKET AND TAX-FREE MUTUAL FUNDS
supporting essential infrastructure projects such as highways, bridges, water and sewage treatment plants, schools, electric and gas utilities, parks, mass transit, and more."Saving on taxes has long been a primary focus for many investors," said Jim Murphy, head of tax-exempt investing at T. Rowe
More news about: T. Rowe Price Group
Jun 08, 2026, 10:30 ET Mass Spectrometry Market worth $10.78 billion by 2031 | MarketsandMarkets™
Mass Spectrometry Market Trends & Insights:By product, the software & services segment is expected to register the highest CAGR of 9.6% during the forecast period.By inlet type, the LC-MS segment held the largest share of 57.5% in the overall mass spectrometry
More news about: MarketsandMarkets
Jun 08, 2026, 10:15 ET Industrial Robotics Market worth $20.80 billion by 2032 - Exclusive Report by MarketsandMarkets™
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=643The increasing need for mass customization and flexible manufacturing is driving the adoption of industrial robotics across production facilities. Companies are increasingly using
More news about: MarketsandMarkets
Jun 08, 2026, 10:01 ET 2026 Protein Market Report: Whey Supply Crisis, FMCG-Led Growth Surge, and Ingredient Import Disruptions Reshape the $133 Billion Industry
scale this fast.GLP-1 adoption has tightened whey demand as protein is increasingly prescribed alongside therapy to preserve lean mass, pushing institutional and retail consumption higher at the same time. US WPC and WPI volumes are largely forward-contracted into 2026, forcing global
More news about: Market Decipher
Jun 08, 2026, 10:00 ET EBSCO Clinical Decisions and AWHONN Partner to Drive Clinical Excellence in Women's Health, Obstetric and Neonatal Nursing
supporting frontline obstetric and neonatal nurses with evidence-based practice at the point of careIPSWICH, Mass., June 8, 2026 /PRNewswire/ --
More news about: EBSCO Information Services
Jun 08, 2026, 09:00 ET Rael Brings K-Beauty's Most Advanced Skincare Ingredients to U.S. Shelves with Two New Hydrogel Masks at Ulta Beauty
category-defining moment for Rael: the brand has officially introduced K-Wellness to the U.S. period care aisle with the first-ever Korean-made tampon in mass retail. The
More news about: Rael
Jun 08, 2026, 08:46 ET Boston Mutual Life Insurance Company Steps Up to the Plate to Sponsor Massachusetts Interscholastic Athletic Association (MIAA) 2026 Baseball State Finals
Massachusetts-based insurer highlights commitment to protecting families and communities through new partnershipCANTON, Mass., June 8, 2026 /PRNewswire/ -- Boston Mutual Life Insurance Company,
More news about: Boston Mutual Life Insurance Company
Jun 08, 2026, 08:41 ET City of Quincy and Cero Global Demonstrate Significant Emission Reductions and Cost Savings
QUINCY, Mass., June 8, 2026 /PRNewswire/ -- The City of Quincy and Boston-based technology firm Cero Global released results of a flagship program aimed at lowering municipal fleet emissions and operating costs. By implementing
More news about: Cero Global
Jun 08, 2026, 08:31 ET MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential
Enhanced Glycemic Control and Body Weight Reduction Versus Monotherapy in a Preclinical T2D ModelCAMBRIDGE, Mass., June 8, 2026 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused
More news about: MetaVia Inc.
Jun 08, 2026, 08:08 ET Neem Medical Spa Expands to Chestnut Hill, Bringing Physician-Led Aesthetic, Longevity, and Wellness Care to Greater Boston
CHESTNUT HILL, Mass., June 8, 2026 /PRNewswire/ -- Neem Medical Spa, founded by Dr. Rosy Sandhu, proudly announces the opening of its newest Massachusetts location at 1006 W Roxbury Parkway, Chestnut Hill, MA 02467, expanding
More news about: Neem Medical Spa
Jun 08, 2026, 08:00 ET Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis
physical particle optimization delivers reproducible methods for increasingly complex biologics.MILFORD, Mass., June 8, 2026 /PRNewswire/ -- 55th International Symposium on High Performance Liquid Phase Separations and
More news about: Waters Corporation
Jun 08, 2026, 08:00 ET Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis
physical particle optimization delivers reproducible methods for increasingly complex biologics.MILFORD, Mass., June 8, 2026 /PRNewswire/ -- 55th International Symposium on High Performance Liquid Phase Separations and
More news about: Waters Corporation
Jun 08, 2026, 08:00 ET Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London
Ingelheim, RA Capital and ILiAD Biotechnologies for discussion on early clinical development CAMBRIDGE, Mass., June 8, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (Nasdaq: DCOY), a biotechnology company pioneering Designable
More news about: Decoy Therapeutics, Inc
Jun 08, 2026, 08:00 ET Apnimed Appoints Experienced Pharmaceutical Executive Kevin R. Lind as Chief Executive Officer to Implement Next Phase of Growth Strategy
Directors, succeeding Mr. Lind, who will continue to serve as an executive member on the BoardCAMBRIDGE, Mass., June 8, 2026 /PRNewswire/ -- Apnimed Inc., a late-stage clinical pharmaceutical company dedicated to the discovery,
More news about: Apnimed, Inc.
Jun 08, 2026, 07:10 ET CTA Construction Managers Awarded Contract for Fox Hill Elementary School in Burlington, Massachusetts
recently awarded the contract to construct the new Fox Hill Elementary School in Burlington, MA.BURLINGTON, Mass. , June 8, 2026 /PRNewswire/ -- CTA Construction Managers is proud to announce it has been awarded the contract
More news about: CTA Construction Managers LLC
Jun 08, 2026, 07:00 ET Plum ProExteriors' Founder, Yuk Slyvka, Named 2026 EY Entrepreneur Of The Year® New England Finalist by EY.
and one of the most decorated exterior renovation companies in New England with him.WELLESLEY, Mass., June 8, 2026 /PRNewswire/ -- Plum ProExteriors announces that its founder and president, Yuk Slyvka, has been
More news about: Plum ProExteriors
Jun 08, 2026, 05:12 ET Pony AI Inc. Announces Results of the Annual General Meeting
June 8, 2026 /PRNewswire/ -- Pony AI Inc. ("Pony.ai" or the "Company") (NASDAQ: PONY; HKEX: 2026), a global leader in achieving large-scale mass production and commercialization of autonomous driving technology, today announced that each of the proposed resolutions submitted for shareholders'
More news about: Pony AI Inc.
Jun 08, 2026, 04:30 ET 2026 ADA | Innovent Presents Multiple Clinical and Preclinical Results of Next-Generation Obesity & Metabolic Pipeline
IBI3046 resulted in a 13% reduction in body weight and a 50% decrease in fat mass relative to control. In combination therapy, IBI3046 administered with a low dose of GLP-1RA achieved 20% body weight loss and a 80% reduction in fat mass. Combining IBI3046 with GLP-1RAs may synergistically enhance fat loss while
More news about: Innovent Biologics
Jun 08, 2026, 02:00 ET New Linux Foundation Report Finds AI is Driving Positive Tech Hiring Trends in Europe Amid Growing Security and Skills Gaps
The Linux Foundation, the nonprofit organization enabling mass innovation through open source, today released its first ever
More news about: The Linux Foundation
Jun 07, 2026, 20:10 ET Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37 and ASC39
Week 13 were 5.4%, 7.0%, and 7.7% for the 20 mg, 40 mg, and 60 mg maintenance doses, respectively. Mean baseline body weight was 107.3 kg, and body mass index (BMI) was 38.6 kg/m². From a safety perspective, ASC30 titrated weekly to the target dose demonstrated approximately one-half the rate of vomiting
More news about: Ascletis Pharma Inc.
Jun 07, 2026, 14:30 ET Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health
weekly injectable delivered substantial and sustained weight loss, with participants losing up to 16.6% of body weight, without compromising muscle mass. The treatment led to visceral fat reductions of up to 34%, targeting the metabolically harmful fat closely linked to insulin resistance, cardiovascular
More news about: American Diabetes Association
Jun 07, 2026, 14:30 ET Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide
Reduction vs. Semaglutide, ≥10% Weight Loss Response Rate Nearly Twofold HigherThis study enrolled 163 adult patients with obesity (body mass index [BMI]≥30 kg/m²) across 17 research centers in China. Participants were randomized 1:1 to receive once-weekly subcutaneous injections of either
More news about: Sciwind Biosciences Co., Ltd.